Inside-Filings
Projekt anfragen

iSpecimen Inc. (ISPC)

Sentiment-Signal

19,8
Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)

Score-Verlauf (90 Tage)

Kritische 8-K Meldungen

WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (23.02.2026)
DatumMeldungSchwereFilingAuszug
23.02.2026Item 5.02 — Abgang SchlüsselpersonenHOCHSEC          Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Offic
07.11.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSEC            Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officer
24.06.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSEC          Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
28.02.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSECother disclosure in the Original Form 8-K.   Item 5.02 Departure of Directors or Certain Officers; Election of Directors
24.02.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSEC          Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
30.12.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSEC          Item 5.02(c). Appointment of Certain Officers.   On December 27, 2024, the Board of Directors (the “Board”) of
20.12.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSEC          Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
12.12.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSEC        Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; C
12.11.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSEC        Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; C
25.09.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSECed by reference in this Item 2.03.   Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appoin
26.03.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSEC          Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
21.12.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSEC        Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Co
07.07.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSEC      Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Comp
25.05.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSEC        Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Co

Stammdaten

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

Unternehmen & Branche

NameiSpecimen Inc.
TickerISPC
CIK0001558569
BoerseUS
SektorHealthcare
IndustrieMedical - Diagnostics & Research
SIC8731 · Services-Commercial Physical & Biological Research

Wertpapier & Kennzahlen

CUSIP–
ISIN–
TypCommon Stock
Marktkapitalisierung625.060 USD
Beta1,98
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-12-3110-K1,928,998-10,487,532-2.289,531,4103,088,231
2025-09-3010-Q106,592-2,780,648-0.488,997,5573,072,711
2025-06-3010-Q713,135-1,047,243-0.426,034,501621,973
2025-03-3110-Q1,057,510-1,658,396-0.716,843,2561,668,513
2024-12-3110-K9,291,115-12,497,805-17.589,350,2303,311,008
2024-09-3010-Q2,661,936-1,439,853-2.1011,264,2234,714,572
2024-06-3010-Q2,863,679-2,109,024-3.7211,901,8586,089,284
2024-03-3110-Q2,289,993-2,902,117-6.3612,513,9016,813,228
2023-12-3110-K9,928,184-11,099,488-24.5515,819,1379,741,077
2023-09-3010-Q2,777,751-2,111,101-4.6616,295,09612,705,720
2023-06-3010-Q1,625,140-3,483,614-0.3917,570,34514,710,575
2023-03-3110-Q2,950,197-2,431,812-0.2721,939,07118,084,494
2022-12-3110-K10,402,303-10,245,922-1.1624,617,65320,309,170
2022-09-3010-Q2,583,412-3,095,690-0.3527,939,93922,423,460
2022-06-3010-Q2,338,688-2,606,809-0.3030,397,45725,297,930
2022-03-3110-Q2,518,660-2,383,742-0.2733,287,31627,667,314
2021-12-3110-K11,135,303-8,961,815-2.0935,719,59829,791,588
2021-09-3010-Q2,718,534-1,553,023-0.2217,622,07212,090,899
2021-06-3010-Q2,903,876-1,394,914-0.8719,605,04210,679,275
2021-03-3110-Q2,963,807-3,963,491-4.23-31,219,422

Fondsaktivität (Vorquartalsvergleich)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.

Top-Fondshalter

Keine Fondsdaten zu dieser Aktie vorhanden.

Hinweis

Erweitert ×